You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

KSK Diagnostics GmbH gains Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds (HTGF) as partners to finance the development of molecular point-of-care diagnostic tests

24. April 2017
KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. A financing round has now been completed with Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds in order to accelerate the development of the product and its More …

Symetis and Boston Scientific reach USD 435 million purchase agreement

7. April 2017
Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease Acquisition projected to close during the second quarter of 2017, subject to customary closing conditions Symetis’ IPO launched on Euronext Paris and very well received by the More …

Dräger acquires majority stake in Hamburg-based start-up bentekk

3. April 2017
Dräger Safety AG & Co. KGaA has acquired a 51 percent stake in bentekk GmbH from seed investors High-Tech Gründerfonds (HTGF) and Innovationsstarter Fonds Hamburg (IFH). This latest acquisition sees Dräger extend its expertise in the area of mobile gas measurement even further. bentekk, based in the south of Hamburg, specializes in developing innovative gas measurement devices for industrial applications. bentekk’s More …

fodjan secures Series A financing and gains new partners

7. March 2017
Technologiegründerfonds Sachsen (TGFS) and High-Tech Gründerfonds (HTGF) are investing in the fast-growing sector of smart farming. Lely Group has also agreed a strategic partnership with the company. Dresden-based start-up fodjan is a specialist in the field of efficient feed management for livestock. The firm’s smart, cloud-based software makes it possible to reduce feed costs, increase operational efficiency while also improving More …

High-Tech Gründerfonds, Bamac GmbH and business angel Markus Plümer invest in animal feed start-up PerformaNat

14. February 2017
Berlin-based start-up PerformaNat specialises in the development of livestock feed additives with a positive effect on animal health. To drive forward the development of new, innovative ingredients, PerformaNat GmbH closed a seven-figure financing round including High-Tech Gründerfonds, Bamac GmbH and business angel Markus Plümer. Berlin-based start-up PerformaNat develops animal-feed additives that optimise the intake of nutrients from animal feed. PerformaNat´s More …

Atriva receives seed financing to develop its next generation influenza therapeutic

7. February 2017
The next generation of Antiviral Therapies: Led by Stichting Participatie Atriva together with High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received seed financing from Dutch and German private investors to advance Atriva’s antiviral MEK-Inhibitors (Mitogen-activated protein kinase kinase inhibitor) against Influenza into the clinical development stage. Atriva Therapeutics stands for the next generation of antiviral therapies. MEK Inhibitors have high More …

Personal MedSystems GmbH gains international consortium and closes series B financing with a volume of EUR 5 million. Further EUR 0.7 million from existing investors expected.

23. January 2017
Personal MedSystems GmbH, founded in 2008 by Dr. Markus Riemenschneider and Felix Brand, adds Dutch investor KPN ventures, Sino German High-Tech Fund from Shenzhen/ Hong Kong and Düsseldorf’s NRW.Bank to its existing investor base, which includes French venture capital firm seventure, the KfW banking group and High-Tech Gründerfonds (HTGF). The capital will be used for sales growth and continued innovation More …

HepaRegeniX GmbH Raises €9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases

5. January 2017
HepaRegeniX GmbH, a new Biotech company developing innovative treatments for liver diseases, announced today the completion of a €9 million Series A financing. The round was led by Boehringer Ingelheim Venture Fund GmbH (BIVF) and Novo Seeds, and complemented by the High-Tech Gruenderfonds and coparion. HepaRegeniX develops a new and unique therapeutic concept for the treatment of liver diseases, discovered More …

Scale-up production, expand US -Sales: JENETRIC GmbH pursues ambitious goals with the third funding round

15. December 2016
The German biometrics company was able to inspire its investors to participate in another investment round and win a new Business Angel After a very successful year, the German biometrics company looks ahead into a financially secure future. JENETRIC’s investors confirmed additional funding for a third investment round. The company was supported by VENTRADA Corporate Finance GmbH in the planning More …

Chinese Biotech Investor VIROAD takes over GILUPI

14. December 2016
The investors AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, the venture capital fund of the Sparkassen of Brandenburg and Business Angels sell their GILUPI shares to the strategic partner VIROAD. GILUPI is a company developing and manufacturing personalized cancer diagnostics in Potsdam. Due to the takeover, GILUPI gets the opportunity to continue the development of its medical products and to diversify More …